Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/189031
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Reprogramming the antigen specificity of B cells using genome-editing technologies

AutorVoss, James E.; González-Martín, Alicia CSIC ORCID ; Andrabi, Raiees; Fuller, Roberta P.; Murrell, Ben; McCoy, Laura E.; Porter, Katelyn; Huang, Deli; Li, Wenjuan; Sok, Devin; Le, Khoa; Briney, Bryan; Chateau, Morgan; Rogers, Geoffrey; Hangartner, Lars; Feeney, Ann J.; Nemazee, David; Cannon, Paula; Burton, Dennis R.
Fecha de publicación2019
EditoreLife Sciences Publications
CitacióneLife 8: e42995 (2019)
ResumenWe have developed a method to introduce novel paratopes into the human antibody repertoire by modifying the immunoglobulin (Ig) genes of mature B cells directly using genome editing technologies. We used CRISPR-Cas9 in a homology directed repair strategy, to replace the heavy chain (HC) variable region in B cell lines with that from an HIV broadly neutralizing antibody (bnAb), PG9. Our strategy is designed to function in cells that have undergone VDJ recombination using any combination of variable (V), diversity (D) and joining (J) genes. The modified locus expresses PG9 HC which pairs with native light chains (LCs) resulting in the cell surface expression of HIV specific B cell receptors (BCRs). Endogenous activation-induced cytidine deaminase (AID) in engineered cells allowed for Ig class switching and generated BCR variants with improved HIV neutralizing activity. Thus, BCRs engineered in this way retain the genetic flexibility normally required for affinity maturation during adaptive immune responses. Peripheral blood derived primary B cells from three different donors were edited using this strategy. Engineered cells could bind the PG9 epitope and sequenced mRNA showed PG9 HC transcribed as several different isotypes after culture with CD40 ligand and IL-4.
Versión del editorhttps://doi.org/10.7554/eLife.42995
URIhttp://hdl.handle.net/10261/189031
DOI10.7554/eLife.42995
E-ISSN2050-084X
Aparece en las colecciones: (IIBM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
reprogtechno.pdf4,48 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

43
checked on 29-mar-2024

SCOPUSTM   
Citations

49
checked on 21-mar-2024

WEB OF SCIENCETM
Citations

46
checked on 25-feb-2024

Page view(s)

181
checked on 28-mar-2024

Download(s)

282
checked on 28-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons